|Mr. Werner Baumann||Chairman of Management & CEO||4.39M||N/A||1962|
|Mr. Johannes M. Dietsch||Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board||2.34M||N/A||1962|
|Mr. Liam Condon||CEO of Bayer Cropscience & Member of Management Board||2.43M||N/A||1968|
|Dr. Kemal Malik||Head of Innovation & Member of Management Board||2.34M||N/A||1962|
|Dr. Hartmut Klusik||Head of HR, Technology & Sustainability, Labor Director and Member of Management Board||2.41M||N/A||1956|
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.
Bayer Aktiengesellschaft’s ISS Governance QualityScore as of April 1, 2018 is 2. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 2.